Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations

Fatigue is a persistent and debilitating feeling of tiredness that limits the ability to perform daily activities and is a common and difficult-to-treat condition in patients with rheumatic diseases (RD). Fatigue is a major challenge for the physician. However, methods to treat it have not yet been...

Full description

Saved in:
Bibliographic Details
Main Authors: E. S. Aronova, B. S. Belov, G. I. Gridneva
Format: Article
Language:Russian
Published: IMA-PRESS LLC 2024-06-01
Series:Современная ревматология
Subjects:
Online Access:https://mrj.ima-press.net/mrj/article/view/1599
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849339546722893824
author E. S. Aronova
B. S. Belov
G. I. Gridneva
author_facet E. S. Aronova
B. S. Belov
G. I. Gridneva
author_sort E. S. Aronova
collection DOAJ
description Fatigue is a persistent and debilitating feeling of tiredness that limits the ability to perform daily activities and is a common and difficult-to-treat condition in patients with rheumatic diseases (RD). Fatigue is a major challenge for the physician. However, methods to treat it have not yet been developed, as fatigue is usually considered an insignificant background condition. This article provides an overview of the 2023 EULAR recommendations, which outline the guiding principles and strategy for the management of fatigue in patients with RD. The EULAR recommendations are based on an understanding of fatigue as a complex condition that requires an individualized approach in choosing the correction methods. It is important that the assessment of fatigue becomes part of the routine practice of rheumatologists and other physicians. Patient education recommendations emphasize the importance of an individualized approach tailored to the needs of the individual, including optimizing physical activity and psychoeducational interventions.
format Article
id doaj-art-3ff4088712be434980df9cbcc6180e25
institution Kabale University
issn 1996-7012
2310-158X
language Russian
publishDate 2024-06-01
publisher IMA-PRESS LLC
record_format Article
series Современная ревматология
spelling doaj-art-3ff4088712be434980df9cbcc6180e252025-08-20T03:44:06ZrusIMA-PRESS LLCСовременная ревматология1996-70122310-158X2024-06-0118312813310.14412/1996-7012-2024-3-128-1332695Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendationsE. S. Aronova0B. S. Belov1G. I. Gridneva2V.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyV.A. Nasonova Research Institute of RheumatologyFatigue is a persistent and debilitating feeling of tiredness that limits the ability to perform daily activities and is a common and difficult-to-treat condition in patients with rheumatic diseases (RD). Fatigue is a major challenge for the physician. However, methods to treat it have not yet been developed, as fatigue is usually considered an insignificant background condition. This article provides an overview of the 2023 EULAR recommendations, which outline the guiding principles and strategy for the management of fatigue in patients with RD. The EULAR recommendations are based on an understanding of fatigue as a complex condition that requires an individualized approach in choosing the correction methods. It is important that the assessment of fatigue becomes part of the routine practice of rheumatologists and other physicians. Patient education recommendations emphasize the importance of an individualized approach tailored to the needs of the individual, including optimizing physical activity and psychoeducational interventions.https://mrj.ima-press.net/mrj/article/view/1599immune-inflammatory rheumatic diseasesfatigueeular recommendations
spellingShingle E. S. Aronova
B. S. Belov
G. I. Gridneva
Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
Современная ревматология
immune-inflammatory rheumatic diseases
fatigue
eular recommendations
title Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
title_full Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
title_fullStr Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
title_full_unstemmed Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
title_short Treatment strategy for fatigue in rheumatic diseases in view of the 2023 EULAR recommendations
title_sort treatment strategy for fatigue in rheumatic diseases in view of the 2023 eular recommendations
topic immune-inflammatory rheumatic diseases
fatigue
eular recommendations
url https://mrj.ima-press.net/mrj/article/view/1599
work_keys_str_mv AT esaronova treatmentstrategyforfatigueinrheumaticdiseasesinviewofthe2023eularrecommendations
AT bsbelov treatmentstrategyforfatigueinrheumaticdiseasesinviewofthe2023eularrecommendations
AT gigridneva treatmentstrategyforfatigueinrheumaticdiseasesinviewofthe2023eularrecommendations